SecBot SecBot
PRESS-RELEASE ·Filed Jul 20, 2026

CAH

Cardinal Health
NEUTRAL
Impact 5/10
Horizonweeks Processed3mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight • Neutral

The acquisitions are small relative to CAH's $53.5B market cap, but they signal continued investment in the at-Home Solutions segment. Monitor integration progress and any impact on Q1 FY27 guidance. The stock may see a modest positive reaction given the accretive nature and strategic fit.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$227.09
T+0 close · Jul 20, 2026 · via day close
Latest settled
+5.56%
T+60 · $239.72
Vs SPY
+1.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $227.09entry
  2. T+1 · 4mo ago −2.88%α −2.77% · $220.54
  3. T+5 · 4mo ago +1.00%α +2.22% · $229.35
  4. T+20 · 3mo ago +3.47%α +0.91% · $234.98
  5. T+60 · 5w ago +5.56%α +1.59% · $239.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cardinal Health announced two tuck-in acquisitions totaling $360M in cash to expand its at-Home Solutions business, acquiring AdaptHealth's diabetes unit and Strive Medical. The deals are small relative to CAH's $53.5B market cap and are expected to be accretive to non-GAAP EPS within 12 months, but the strategic impact is modest and routine for a diversified healthcare distributor.

Key Financial Metrics

Deal Value
$360.0M

Key Facts

  • Combined acquisition price of approximately $360 million in cash, subject to working capital adjustments.
  • Acquires AdaptHealth's Diabetes Health business (serving >225,000 patients annually) and Strive Medical (serving >20,000 patients, specializing in urology, wound care, ostomy, and incontinence).
  • Expected to be accretive to non-GAAP EPS within the first 12 months post-close.
  • Transactions are subject to customary closing conditions and regulatory approvals.
  • Builds on the prior acquisition of Advanced Diabetes Supply (ADS) and the at-Home Solutions platform.

Financial Impact

Two tuck-in acquisitions for $360M total, expanding home care capabilities in diabetes and urology. Expected to be accretive to non-GAAP EPS within 12 months.

revenueepsdilution

Risk Factors

  • Integration risk from folding two distinct businesses into at-Home Solutions platform.
  • Regulatory approval delays or conditions could alter deal terms.
  • Competitive pressure in home care distribution may limit margin expansion.

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302829980

Track record

17 reports on CAH

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today 3 Neutral 2/10 Entry $283.50 Now $283.85 +0.12% settles Nov 24
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $283.35 Now $283.85 −0.18% settles Nov 23
  3. Nov 11, 20265d ago Press Release Neutral 2/10 Entry $278.14 Now $283.85 +2.05% settles Nov 19
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $267.82 to $278.14 Now $283.85 +5.99% ▲ +3.85% +0.56% vs SPY
  5. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $251.09 to $267.82 Now $283.85 +13.05% ▲ +6.66% +11.39% vs SPY
  6. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $244.76 to $261.93 Now $283.85 +15.97% ▲ +7.01% +7.73% vs SPY
  7. Oct 27, 202621d ago GOVT-CONTRACT Neutral 4/10 Entry $244.76 to $261.93 Now $283.85 +15.97% ▲ +7.01% +7.73% vs SPY
  8. Oct 1, 20266w ago 8-K Neutral 5/10 Entry $230.09 to $238.96 Now $283.85 +23.36% ▲ +3.85% +2.55% vs SPY
  9. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $230.09 to $238.96 Now $283.85 +23.36% ▲ +3.85% +2.55% vs SPY
  10. Aug 20, 202612w ago Insider Cluster Neutral 4/10 Entry $228.46 to $235.13 Now $283.85 +24.24% ▲ +2.92% +1.80% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 9h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026